Blood test aims to unmask hidden TB infections before they turn deadly
NCT ID NCT06751706
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This study investigates whether a blood test can detect the bacteria that cause tuberculosis (TB) in people with active TB and their asymptomatic household contacts. Researchers in Uganda will use several methods, including a DNA-based test, to look for TB bacteria in blood samples. The goal is to develop a better way to identify individuals with latent TB who are at highest risk of developing active disease, so they can receive preventive treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a better blood test to identify who is at highest risk of developing active TB, allowing targeted preventive therapy.
What could go wrong
This is a small, early-stage study (60 participants) focused on detection methods, not treatment. The test may not prove accurate enough for widespread use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Comparing eDOT vs. In-Person DOT for TB Treatmen NCT03266003
- TBnet Registry: Tuberculosis Data Collection in NCT07677904
- Antigen-Specific T Cells for Opportunistic Infec NCT03159364
- Lipovaxin TB Vaccine Trial (NCT07647107)
- Delamanid for MDR-TB in Children Trial (NCT03141060)
- TB Drug Trial: TBAJ-876 vs Bedaquiline (NCT06058299)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Infectious diseases institute, Makarere University
Kampala, P.O. Box 22418, Uganda